GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
US10857221B2 · kind B2 · utility
1Cited by
14References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2019 |
| Grant date | Dec 8, 2020 |
| Priority date | — |
| Expiry date | Oct 8, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally provides methods and compositions for eliciting an immune response against Neisseria spp. bacteria in a subject, particularly against a Neisseria meningitidis serogroup B strain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.